Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,020 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Update on the treatment of neuroendocrine tumors.
Bajetta E, Procopio G, Ferrari L, Catena L, Del Vecchio M, Bombardieri E. Bajetta E, et al. Among authors: ferrari l. Expert Rev Anticancer Ther. 2003 Oct;3(5):631-42. doi: 10.1586/14737140.3.5.631. Expert Rev Anticancer Ther. 2003. PMID: 14599087 Review.
Lanreotide autogel every 6 weeks compared with Lanreotide microparticles every 3 weeks in patients with well differentiated neuroendocrine tumors: a Phase III Study.
Bajetta E, Procopio G, Catena L, Martinetti A, De Dosso S, Ricci S, Lecchi AS, Boscani PF, Iacobelli S, Carteni G, De Braud F, Loli P, Tartaglia A, Bajetta R, Ferrari L. Bajetta E, et al. Among authors: ferrari l. Cancer. 2006 Nov 15;107(10):2474-81. doi: 10.1002/cncr.22272. Cancer. 2006. PMID: 17054107 Free article. Clinical Trial.
Treatment of cancer-related anemia with epoetin alfa: a review.
Ferrario E, Ferrari L, Bidoli P, De Candis D, Del Vecchio M, De Dosso S, Buzzoni R, Bajetta E. Ferrario E, et al. Among authors: ferrari l. Cancer Treat Rev. 2004 Oct;30(6):563-75. doi: 10.1016/j.ctrv.2004.04.005. Cancer Treat Rev. 2004. PMID: 15325036 Review.
Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: results from a randomised trial of exemestane vs megestrol acetate.
Martinetti A, Zilembo N, Ferrari L, Massimini G, Polli A, La Torre I, Giovanazzi R, Pozzi P, Bidoli P, De Candis D, Seregni E, Bombardieri E, Bajetta E. Martinetti A, et al. Among authors: ferrari l. Anticancer Res. 2003 Jul-Aug;23(4):3485-91. Anticancer Res. 2003. PMID: 12926095 Clinical Trial.
1,020 results